The BC Bud Corporation
$0.04-$0.00 (-3.31%)
The BC Bud Corporation’s quoted price sits in the lower half of its reported 52-week range, 68.95% below the high.
OTC · CHNC · USD
Stock price
Quote as of Aug 16, 2023, 07:21 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
China Infrastructure Construction Corp. (CHNC), founded in Houston, Texas, in 2003, is primarily an educational provider specializing in medical cannabis. The company delivers its cannabis-focused curricula throughout the United States and Latin America, also offering worldwide access via online platforms. Beyond its educational endeavors, CHNC furnishes a range of therapeutic services. These include the execution of clinical trials and the operation of a dedicated fertility and sleep center situated in Houston, Texas. This center specifically addresses sleep-related conditions, particularly those that result in infertility. Additionally, through its division, Pharmacology University, CHNC provides a comprehensive array of services related to medical cannabis, including instruction, advisory support, digital content creation, promotional activities, and licensing for franchise operations.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.04-$0.00 (-3.31%)
The BC Bud Corporation’s quoted price sits in the lower half of its reported 52-week range, 68.95% below the high.
$0.04$0.00 (0.0%)
CLS Holdings USA, Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.54% below the high.
A$0.02A$0.00 (0.0%)
Epsilon Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 47.5% below the high.
$0.02+$0.00 (+4.79%)
VIVO Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.5% below the high.
$0.12-$0.10 (-44.37%)
Fire & Flower Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 31.43% below the high.
$0.12+$0.00 (+2.52%)
Acreage Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.06% below the high.
$0.02+$0.00 (+6.19%)
Indiva Limited’s quoted price sits in the upper half of its reported 52-week range, 4.29% below the high.
$0.00+$0.00 (+9,900.0%)
Invictus MD Strategies Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.